Correlation Between Pharvaris and RepliCel Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharvaris and RepliCel Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and RepliCel Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and RepliCel Life Sciences, you can compare the effects of market volatilities on Pharvaris and RepliCel Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of RepliCel Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and RepliCel Life.

Diversification Opportunities for Pharvaris and RepliCel Life

-0.66
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pharvaris and RepliCel is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and RepliCel Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RepliCel Life Sciences and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with RepliCel Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RepliCel Life Sciences has no effect on the direction of Pharvaris i.e., Pharvaris and RepliCel Life go up and down completely randomly.

Pair Corralation between Pharvaris and RepliCel Life

Given the investment horizon of 90 days Pharvaris BV is expected to under-perform the RepliCel Life. But the stock apears to be less risky and, when comparing its historical volatility, Pharvaris BV is 39.52 times less risky than RepliCel Life. The stock trades about -0.17 of its potential returns per unit of risk. The RepliCel Life Sciences is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  0.58  in RepliCel Life Sciences on September 4, 2024 and sell it today you would lose (0.38) from holding RepliCel Life Sciences or give up 65.52% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pharvaris BV  vs.  RepliCel Life Sciences

 Performance 
       Timeline  
Pharvaris BV 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Pharvaris BV are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Pharvaris unveiled solid returns over the last few months and may actually be approaching a breakup point.
RepliCel Life Sciences 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in RepliCel Life Sciences are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental indicators, RepliCel Life reported solid returns over the last few months and may actually be approaching a breakup point.

Pharvaris and RepliCel Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharvaris and RepliCel Life

The main advantage of trading using opposite Pharvaris and RepliCel Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, RepliCel Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RepliCel Life will offset losses from the drop in RepliCel Life's long position.
The idea behind Pharvaris BV and RepliCel Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum